proS Resolved · high auto-curated

H37Rv Rv2845c · MTBC0 mtbc0_003024 · 582 aa · 3171868–3173616 MTBC0 (-) · RefSeq NP_217361.1

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)proline--tRNA ligase
MTBC0 PGAP re-annotationproline--tRNA ligase
Revised (this work)Proline--tRNA ligase. Pfam: tRNA-synt_2b (PF00587.31), tRNA_edit (PF04073.21), HGTP_anticodon (PF03129.26).
Functional category (TubercuList)information pathways

Curation note: P16.22 (phase134, 2026-08-17): couche pupylome ajoutee (1 peptide(s) confirme(s), percentile PaxDb 89.4).

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) 69 publications

69 TB publications mention this gene. 69 publications discuss this gene. Queried separately, 70 records carry a M. tuberculosis context and 3 a non-TB mycobacterial context (species named in the 3-record verified sample: M. leprae (3), M. marinum (1), M. smegmatis (1)). The three counts come from three distinct PubMed queries (each with its own context filter), so they neither partition the total nor need to add up to it.

5 of 69: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
Treating tuberculosis without rifampicin: an open dilemma. doi:10.1016/j.rmed.2026.109002 2026
Amikacin liposome inhalation suspension in newly diagnosed Mycobacterium avium complex lung disease (ARISE): a 6-month double-blind, active comparator trial. doi:10.1093/annalsats/aaoaf064 2026
Patient-reported outcomes in tuberculosis: a qualitative exploration of psychosocial, economic, and treatment-related challenges. doi:10.36416/1806-3756/e20250159 2025
Model systems to study Mycobacterium tuberculosis infections: an overview of scientific potential and impediments. doi:10.3389/fcimb.2025.1572547 2025
Application of Metagenomic and Targeted Next-Generation Sequencing in Diagnosis of Pulmonary Tuberculosis in Bronchoalveolar Lavage Fluid. doi:10.2147/IDR.S514090 2025
78 records returned by the alias sweep (a separate sweep from the 69 above; both are shown, neither is exhaustive)

Searched as: Rv2845c, proS, Mb2870c, MMAR_1888, MSMEG_2621, MAB_3140c — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

PublicationJournalYear
Fluorine-Induced Elimination Drives Mechanism-Based Inactivation of Isocitrate Lyase. doi:10.1021/acs.biochem.6c00478 Biochemistry 2026
Treating tuberculosis without rifampicin: an open dilemma. doi:10.1016/j.rmed.2026.109002 Respir Med 2026
Amikacin liposome inhalation suspension in newly diagnosed Mycobacterium avium complex lung disease (ARISE): a 6-month double-blind, active comparator trial. doi:10.1093/annalsats/aaoaf064 Ann Am Thorac Soc 2026
Patient-reported outcomes in tuberculosis: a qualitative exploration of psychosocial, economic, and treatment-related challenges. doi:10.36416/1806-3756/e20250159 J Bras Pneumol 2025
Model systems to study Mycobacterium tuberculosis infections: an overview of scientific potential and impediments. doi:10.3389/fcimb.2025.1572547 Front Cell Infect Microbiol 2025
Application of Metagenomic and Targeted Next-Generation Sequencing in Diagnosis of Pulmonary Tuberculosis in Bronchoalveolar Lavage Fluid. doi:10.2147/IDR.S514090 Infect Drug Resist 2025
Advanced Artificial Intelligence Technologies Transforming Contemporary Pharmaceutical Research. doi:10.3390/bioengineering12040363 Bioengineering (Basel) 2025
A predictive score for early in-patient tuberculosis mortality: A case-control study. doi:10.1016/j.jctube.2024.100487 J Clin Tuberc Other Mycobact Dis 2024
Assessment of health-related quality of life in patients with nontuberculous mycobacterial pulmonary disease: A comprehensive review. doi:10.1016/j.resinv.2024.08.009 Respir Investig 2024
[Efficacy and safety of first-line anti-tuberculosis drugs combined with Linezolid for the treatment of pediatric tuberculous meningitis in real-word practice]. doi:10.3760/cma.j.cn112140-20240524-00361 Zhonghua Er Ke Za Zhi 2024
Patient-reported outcomes for the phase 3 FURLONG study of furmonertinib versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer. doi:10.1016/j.lanwpc.2024.101122 Lancet Reg Health West Pac 2024
People first: a participatory community approach on patient-reported outcomes in tuberculosis. doi:10.1183/20734735.0138-2023 Breathe (Sheff) 2024
Screening for Latent Tuberculosis. doi:10.1001/jama.2023.6495 JAMA 2023
Patient-Reported Symptom and Health-Related Quality-of-Life Validation and Responsiveness During the First 6 Months of Treatment for Mycobacterium avium Complex Pulmonary Disease. doi:10.1016/j.chest.2023.02.015 Chest 2023
Global realignment after posterior vertebral column resection in severe thoracolumbar post-tubercular kyphosis: correlation with patient-reported outcomes. doi:10.1007/s00264-022-05620-w Int Orthop 2023
Recent advances in airborne pathogen detection using optical and electrochemical biosensors. doi:10.1016/j.aca.2022.340297 Anal Chim Acta 2022
Utility and Limits of Lung Ultrasound in Childhood Pulmonary Tuberculosis: Lessons from a Case Series and Literature Review. doi:10.3390/jcm11195714 J Clin Med 2022
THP-1 cell line model for tuberculosis: A platform for in vitro macrophage manipulation. doi:10.1016/j.tube.2022.102243 Tuberculosis (Edinb) 2022
Global Spinal Realignment After Osteotomized Debridement in Active Lumbar Spinal Tuberculosis: Correlation with Patient-Reported Outcomes. doi:10.1016/j.wneu.2022.05.120 World Neurosurg 2022
[Cryptococcal Meningitis with Inadequate Response to Antifungal Therapy or Drug-Induced Side Effects That Make It Difficult to Continue Treatment: Eleven Clinical Issues in Medical Practice]. doi:10.11477/mf.1416202085 Brain Nerve 2022
Laboratory perspectives for Leprosy: Diagnostic, prognostic and predictive tools. doi:10.4103/ijpm.ijpm_1083_21 Indian J Pathol Microbiol 2022
CRISPR-Cas systems for diagnosing infectious diseases. doi:10.1016/j.ymeth.2021.04.007 Methods 2022
Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence. doi:10.1016/j.pulmoe.2020.12.016 names it Pulmonology 2021
The Strange Case of BCG and COVID-19: The Verdict Is Still up in the Air. doi:10.3390/vaccines8040612 Vaccines (Basel) 2020
Needs with Regard to Decision Support Systems for Treating Patients with Incurable Non-small Cell Lung Cancer. doi:10.1007/s13187-019-1471-8 J Cancer Educ 2020
Simulations of Shikimate Dehydrogenase from Mycobacterium tuberculosis in Complex with 3-Dehydroshikimate and NADPH Suggest Strategies for MtbSDH Inhibition. doi:10.1021/acs.jcim.8b00834 J Chem Inf Model 2019
Health-Related Quality of Life (HRQoL) scores vary with treatment and may identify potential defaulters during treatment of tuberculosis. doi:10.4314/mmj.v30i4.12 Malawi Med J 2018
Commentary: The pros of plurality for tuberculosis burden estimates. doi:10.1093/ije/dyy147 names it Int J Epidemiol 2018
[Development and application of artificial vertebral body]. doi:10.3969/j.issn.1003-0034.2017.12.017 Zhongguo Gu Shang 2017
Lamivudine monotherapy in children and adolescents: The devil is in the detail. doi:10.7196/SAMJ.2017.v107i12.12776 S Afr Med J 2017
Precise Probing of Residue Roles by Post-Translational β,γ-C,N Aza-Michael Mutagenesis in Enzyme Active Sites. doi:10.1021/acscentsci.7b00341 ACS Cent Sci 2017
Genome editing in livestock: Are we ready for a revolution in animal breeding industry? doi:10.1007/s11248-017-0049-7 Transgenic Res 2017
Pros and cons of direct genotyping on tuberculosis clinical samples. doi:10.1016/j.micpath.2016.12.025 names it Microb Pathog 2017
Is it possible to standardize the treatment of primary spontaneous pneumothorax? Part 2: surgical methods of treatment. doi:10.5114/kitp.2016.64875 Kardiochir Torakochirurgia Pol 2016
Is it possible to standardize the treatment of primary spontaneous pneumothorax? Part 1: etiology, symptoms, diagnostics, minimally invasive treatment. doi:10.5114/kitp.2016.64874 Kardiochir Torakochirurgia Pol 2016
The pros and cons of the QuantiFERON test for the diagnosis of tuberculosis, prediction of disease progression, and treatment monitoring. doi:10.1016/j.ijmyco.2016.02.005 names it Int J Mycobacteriol 2016
Health-related quality of life and its association with medication adherence in active pulmonary tuberculosis- a systematic review of global literature with focus on South Africa. doi:10.1186/s12955-016-0442-6 Health Qual Life Outcomes 2016
Review article: Surgical approaches for correction of post-tubercular kyphosis. doi:10.1177/230949901502300328 J Orthop Surg (Hong Kong) 2015
Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. doi:10.1517/14712598.2015.1103733 Expert Opin Biol Ther 2015
Isolated tuberculous lymphadenitis presenting as bilateral buboes. doi:10.4103/0253-7184.156739 Indian J Sex Transm Dis AIDS 2015
Hacking into the granuloma: could antibody antibiotic conjugates be developed for TB? doi:10.1016/j.tube.2014.08.009 Tuberculosis (Edinb) 2014
[Frederic Chopin (1810-1849), and his disease]. doi:10.4067/S0034-98872014000400018 Rev Med Chil 2014
Pros and cons of the tuberculosis drugome approach--an empirical analysis. doi:10.1371/journal.pone.0100829 names it PLoS One 2014
Developments and strategies for inhaled antibiotic drugs in tuberculosis therapy: a critical evaluation. doi:10.1016/j.ejpb.2013.10.019 Eur J Pharm Biopharm 2014
Interferon γ-release assays for diagnosis of latent tuberculosis in healthcare workers in low-incidence settings: pros and cons. doi:10.1373/clinchem.2012.201178 names it Clin Chem 2014
True facets of TB diagnosis in 2012: Hypes and realities. doi:10.1556/EuJMI.2.2012.4.5 Eur J Microbiol Immunol (Bp) 2012
The pros and cons of urinary lipoarabinomannan testing. doi:10.1097/QAD.0b013e3283573286 names it AIDS 2012
An update on vaccines for tuberculosis - there is more to it than just waning of BCG efficacy with time. doi:10.1517/14712598.2012.721768 Expert Opin Biol Ther 2012
Methodology matters: what type of research is suitable for evaluating community treatment supporters for HIV and tuberculosis treatment? doi:10.1111/j.1365-3156.2011.02920.x Trop Med Int Health 2012
Medical controversies and dilemmas in discussions about the illness and death of Mihai Eminescu (1850-1889) Romania's national poet. Med Probl Perform Art 2011
Closing-opening wedge osteotomy for severe, rigid, thoracolumbar post-tubercular kyphosis. doi:10.1007/s00586-010-1526-3 Eur Spine J 2011
Turning off the spigot: reducing drug-resistant tuberculosis transmission in resource-limited settings. Int J Tuberc Lung Dis 2010
[Fixed drug combinations--the pros and the cons]. names it Med Monatsschr Pharm 2009
Bacterial immunostimulants--mechanism of action and clinical application in respiratory diseases. Pneumonol Alergol Pol 2008
Trans-epithelial immune cell transfer during suckling modulates delayed-type hypersensitivity in recipients as a function of gender. doi:10.1371/journal.pone.0003562 PLoS One 2008
The Mycobacterium tuberculosis Rv2540c DNA sequence encodes a bifunctional chorismate synthase. doi:10.1186/1471-2091-9-13 BMC Biochem 2008
Multidrug resistant tuberculosis in a 6 year old child. doi:10.1016/j.prrv.2007.07.006 Paediatr Respir Rev 2007
The futility of universal pre-employment chest radiographs. J Natl Med Assoc 2006
Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein (ACP) reductase: kinetic and chemical mechanisms. doi:10.1021/bi0611210 Biochemistry 2006
A fragment of 21 ORFs around the direct repeat (DR) region of Mycobacterium tuberculosis is absent from the other sequenced mycobacterial genomes: implications for the evolution of the DR region. doi:10.1002/cfg.380 Comp Funct Genomics 2004
Polymer based drug delivery systems for mycobacterial infections. doi:10.2174/1567201043334669 Curr Drug Deliv 2004
Characterization of a new member of the flavoprotein disulfide reductase family of enzymes from Mycobacterium tuberculosis. doi:10.1074/jbc.M410704200 J Biol Chem 2004
Kinetic and chemical mechanism of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate isomeroreductase. doi:10.1021/bi049974k Biochemistry 2004
Cystic fibrosis--a probable cause of Frédéric Chopin's suffering and death. J Appl Genet 2003
Mycobacterium tuberculosis lipoamide dehydrogenase is encoded by Rv0462 and not by the lpdA or lpdB genes. doi:10.1021/bi010575o Biochemistry 2001
Effects of TENS and methylphenidate in tuberculous meningo-encephalitis. doi:10.1080/02699050010007399 Brain Inj 2001
Tuberculosis vaccine development: recent progress. doi:10.1016/s0966-842x(00)01949-1 Trends Microbiol 2001
Polymerase chain reaction and other amplification techniques in mycobacteriology. Clin Lab Med 1996
Pros and cons of BCG vaccination in countries with low incidence of tuberculosis. doi:10.1086/646958 names it Infect Control Hosp Epidemiol 1994
Fans, filters, or rays? Pros and cons of the current environmental tuberculosis control technologies. doi:10.1086/646669 names it Infect Control Hosp Epidemiol 1993
Changing case-definition for AIDS. Lancet 1992
Tissue response to lepromin, an index of susceptibility of the armadillo to M. leprae infection--a preliminary report. Int J Lepr Other Mycobact Dis 1982
[Mass radiography. The "pros and cons" of a classic method of preventive medicine (author's transl)]. names it MMW Munch Med Wochenschr 1980
Problems of drug resistance in tuberculosis--the newer anti-tuberculosis drugs. doi:10.1136/pgmj.47.553.748 Postgrad Med J 1971
[ADRENAL CRISIS IN A CASE OF GENERALIZED MILIARY TUBERCULOSIS]. Gruzlica (1926) 1965
[A CASE OF THROMBOCYTOPENIA IN MILIARY TUBERCULOSIS WITH NEGATIVE ANERGY]. Gruzlica (1926) 1963
[Pros and cons of section and suture of the bronchus in the treatment of tuberculous cavitations]. names it Torax 1962
[Catalase activity and virulence of Mycobacterium tuberculosis strains resistant to isoniazid]. Delt Hell Mikrobiol Hygieinol Hetair 1957

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

Conditional expression context (iModulons)

Member of 1 independently-modulated gene set(s): Fatty Acid Biosynthesis (trcR and Rv1776c and whiB4 ).

iModulon membership (independently-modulated gene sets from a 647-sample RNA-seq compendium): the conditional co-expression context. Co-expression is a regulatory context, NOT a molecular function. Source: iModulonDB / modulome_mtb (Yoo 2022).

Pupylome (Pup conjugation, actinobacteria-specific)

1 MS-confirmed pupylation peptide(s) (modified lysine marked '#'): K.DSYSFDIDAAGLK#AAYHAHR.E. This protein's PaxDb abundance percentile is 89.4.

MS-confirmed Pup (prokaryotic ubiquitin-like protein) conjugation site(s), identified directly in M. tuberculosis (not inferred from M. smegmatis orthology). A pupylation site marks the protein as a substrate of the Pup-proteasome degradation/regulatory system -- it is a REGULATORY CONTEXT, NOT a molecular function. CAVEAT (checked against our own PaxDb abundance layer, P16.22): across the 55 MS-confirmed targets in this dataset, the median PaxDb abundance percentile is 89.4 and 54/55 lie above the whole-proteome median -- detection by affinity-purification + MS is strongly confounded with protein abundance, so the ABSENCE of a pupylation site on a low-abundance gene is a detection blind spot, not evidence of biological absence. Source: Festa et al. 2010 (PLoS ONE), Table S2 -- tandem affinity purification + MS on M. tuberculosis, 55/604 candidates with MS-confirmed site(s).

CRISPRi vulnerability

Vulnerability index -8.98 (95% CI -10.16 to -7.82). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Legacy record & comparison (Mycobrowser)

Mycobrowser functionInvolved in translation mechanism [catalytic activity: ATP + L-proline + tRNA(pro) = AMP + pyrophosphate + L-prolyl-tRNA(pro)].
Mycobrowser EC 6.1.1.15 · agrees with the atlas

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb2870c · 99.5% identity
M. marinum MMAR_1888 · 89.2% identity
M. smegmatis MSMEG_2621 · 81.4% identity
M. orygis RJtmp_002933 · 99.7% identity
M. abscessus MAB_3140c · 81.9% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt P9WFT9 SwissProt · reviewed · Evidence at protein level
UniProt nameProline--tRNA ligase
EC (curated) EC 6.1.1.15
Curated functionCatalyzes the attachment of proline to tRNA(Pro) in a two-step reaction: proline is first activated by ATP to form Pro-AMP and then transferred to the acceptor end of tRNA(Pro). As ProRS can inadvertently accommodate and process non-cognate amino acids such as alanine and cysteine, to avoid such errors it has two additional distinct editing activities against alanine. One activity is designated as 'pretransfer' editing and involves the tRNA(Pro)-independent hydrolysis of activated Ala-AMP. The other activity is designated 'posttransfer' editing and involves deacylation of mischarged Ala-tRNA(P.

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category J Translation, ribosomal structure and biogenesis
Preferred nameproS
eggNOG descriptionCatalyzes the attachment of proline to tRNA(Pro) in a two-step reaction proline is first activated by ATP to form Pro- AMP and then transferred to the acceptor end of tRNA(Pro). As ProRS can inadvertently accommodate and process non-cognate amino acids such as alanine and cysteine, to avoid such errors it has two additional distinct editing activities against alanine. One activity is designated as 'pretransfer' editing and involves the tRNA(Pro)-independent hydrolysis of activated Ala-AMP. The other activity is designated 'posttransfer' editing and involves deacylation of mischarged Ala-tRNA(Pro). The misacylated Cys- tRNA(Pro) is not edited by ProRS
Orthologous groupCOG0442
EC number EC 6.1.1.15
KEGG orthology K01881
KEGG pathways map00970
KEGG modules M00359, M00360
Gene Ontology (10) GO:0005575, GO:0005618, GO:0005623, GO:0005886, GO:0008150, GO:0016020, GO:0030312, GO:0040007, GO:0044464, GO:0071944

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.416 · purifying
Polymorphic sites (≥ 0.1% of strains) 5 synonymous, 6 missense, 0 nonsense, 0 frameshift

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Bacteria

M. canettii dN/dS (deep-divergence selection) 0.087 (low power) · 5 consensus substitution(s)
low power (5 canettii-consensus substitution(s)); present in M. canettii but dN/dS not reliable
Limitation: dN/dS mixes fixed canettii-H37Rv divergence with intra-canettii polymorphism, and is not polarised (the per-gene repolarisation is not viable: 79 % of the consensus SPDI lie outside the polarised table).
Genus-wide presence (~53 non-MTBC Mycobacterium) present in 51/53 (96%) · mean identity 88.9% · 4/4 closest MTBAP relatives
conserved across the genus (present in 51/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 13/13 non-Mycobacterium reference genomes (down to Bacteria) · mean identity 64.3%
detected down to outside the phylum (Proteobacteria/Firmicutes controls) — a universally conserved, ancient bacterial gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis) essential

DeJesus 2017 callES · essential
What the call meansessential: insertions absent across the whole ORF
TA sites (Himar1) 31 in the ORF — 30 in the essential state, 0 growth-defect, 1 non-essential, 0 growth-advantage. Saturation 0.065, mean read count 81.5. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 31 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Chemical-genetic target & druggability (PROSPECT) hypomorph tool strain

This gene is part of the PROSPECT collection of TetON transcriptional-knockdown (hypomorph) strains of essential M. tuberculosis genes, built as a sensitised background for chemical-genetic mechanism-of-action deconvolution. Being in the panel means the gene is an essential / vulnerable target for which a validated knockdown tool strain exists.

Hypomorph strainproS-FLAG-tetOn-1 (TetON promoter 1)
Baseline knockdown fitness0.917 median doublings (across 6 screen pool(s)) — fewer doublings = stronger growth defect on knockdown
Used in target deconvolutionno (Excluded - slow growth (less than 1 doubling in a screening wave))

Panel membership reflects essentiality/vulnerability and the availability of a genetic tool, not a specific molecular function; it never changes the verdict here. Source: Bond AN et al., Nat Commun 2025;16:9673 (doi:10.1038/s41467-025-64662-x); PROSPECT chemical-genetic platform.

Proteomics (mass spectrometry) detected

MS detectiondetected in 15 of 16 independent MS datasets
Integrated abundance555.0 ppm · rank 373/3519 (89.4th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox) no export signal, no TM helix

Predictionno signal peptide, no TM helix (DeepTMHMM class GLOB)
DeepTMHMM classGLOB

A verified absence of signals, which is not a compartment. No Sec/Tat signal peptide, no transmembrane helix and no lipobox were found on this sequence. The predictor reports topology and export signals; it does not measure where the protein ends up, so this page draws no cytoplasmic conclusion from it. In M. tuberculosis that reservation is not theoretical: the 12 Esx paralogues of this atlas — EsxA/ESAT-6 and EsxB/CFP-10 among them, the best-established secreted proteins of the species — carry this very call, because substrates of the type VII (ESX) secretion system leave no recognisable signal. « Secreted » and « no signal peptide » are true together here.

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length582 aa
Molecular weight63.3 kDa
Theoretical pI5.07
GRAVY-0.138 (hydrophilic)
Aliphatic index94.9
Aromaticity0.076
Instability index30.6 (stable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
tRNA-synt_2bPF00587.31 2.9e-2596–471 tRNA synthetase class II core domain (G, H, P, S and T)
tRNA_editPF04073.21 2.6e-14280–387 Aminoacyl-tRNA editing domain
HGTP_anticodonPF03129.26 8.9e-13490–565 Anticodon binding domain

3D structure (interactive — Mol*/pdbe-molstar)

No experimental structure is deposited for this gene: showing the AlphaFold DB predicted model (mean pLDDT 95.2, very high), coloured by per-residue confidence (dark blue = very high, orange/red = low — treat low-confidence regions as unreliable, especially termini and loops). Drag to rotate, scroll to zoom.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 95.2

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
8w9i-assembly1_A 1.00 0.92 0.90 0.92 40% 100% / 100% 5.2e-70 sig 8w9i-assembly1_A Crystal structure of bacterial prolyl-tRNA synthetase in complex with inhibitor PAA-5
5znk-assembly1_A 1.00 0.89 0.86 0.89 38% 100% / 100% 3.1e-69 sig 5znk-assembly1_A Crystal structure of a bacterial ProRS with ligands
8w8j-assembly1_B 1.00 0.91 0.89 0.91 40% 100% / 100% 2.9e-68 sig 8w8j-assembly1_B Crystal structure of bacterial prolyl-tRNA synthetase in complex with inhibitor PAA-19
5znj-assembly1_A-2 1.00 0.88 0.85 0.88 38% 100% / 99% 7.0e-69 sig 5znj-assembly1_A-2 Crystal structure of a bacterial ProRS with ligands
2j3m-assembly1_A 1.00 0.92 0.87 0.92 39% 99% / 100% 4.7e-68 sig 2j3m-assembly1_A PROLYL-TRNA SYNTHETASE FROM ENTEROCOCCUS FAECALIS COMPLEXED WITH ATP, manganese and prolinol

Foldseek search of the AlphaFold DB model (mean pLDDT 95.2, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon)

Upstream (5' on genome)Rv2844 (+ strand, 0 bp gap)
Downstream (3' on genome)efpA (- strand, 88 bp gap)

Neighbours from the H37Rv annotation (- strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) no multi-gene operon predicted (singleton)
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT2911) exponential phase: operon of 3, Rv2845c · Rv2846c · Rv2847c (coverage 55.66)
not expressed (stationary phase) — disagrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: efpA (MFS-type transporter EfpA), high confidence (score 740, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence).

Showing the 15 strongest of this gene's 73 partners at medium confidence (17 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. None of the 73 partners rests on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv1536 ileS exp (transferred) curated isoleucine--tRNA ligase 993 987 coexpression:763 experimental:875 database:597 textmining:513
Rv2992c gltS exp (transferred) curated glutamate--tRNA ligase 972 962 coexpression:434 experimental:852 database:546
Rv1292 argS exp (transferred) curated arginine--tRNA ligase 957 940 coexpression:704 experimental:512 database:597
Rv1007c metS exp (transferred) curated methionine--tRNA ligase 990 907 coexpression:425 experimental:629 database:571 textmining:900
Rv0041 leuS exp (transferred) curated leucine--tRNA ligase 930 868 coexpression:415 experimental:467 database:597 textmining:494
Rv1640c lysX exp (transferred) bifunctional lysine--tRNA ligase/phosphatidylglycerol lysyltransferase 883 806 coexpression:411 experimental:473 textmining:421
Rv3598c lysS exp (transferred) lysine--tRNA ligase 889 803 coexpression:416 experimental:473 textmining:462
Rv3396c guaA GMP synthase 807 753 coexpression:695
Rv2846c efpA MFS-type transporter EfpA 740 740 ctx neighborhood:736
Rv1699 pyrG CTP synthase 725 726 coexpression:719
Rv1087A Rv1087A, len: 106 aa (fragment). Conserved hypothetical protein, highly similar to C-terminus of near ORF O53434|YA86_MYCTU|Rv1086|MT1118|MT 700 700 coexpression:647
Rv2361c uppS decaprenyl diphosphate synthase 689 689 coexpression:647
Rv1650 pheT phenylalanine--tRNA ligase subunit beta 839 682 coexpression:583 textmining:517
Rv0823c dusB curated tRNA-dihydrouridine synthase 698 679 database:647
Rv2462c tig trigger factor 701 673 coexpression:654

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: proline--tRNA ligase
  • MTBC0 PGAP product: proline--tRNA ligase
  • Pfam (hmmscan --cut_ga): tRNA-synt_2b PF00587.31 (E=3e-25), tRNA_edit PF04073.21 (E=3e-14), HGTP_anticodon PF03129.26 (E=9e-13)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_217361.1)
  • Domains: Pfam-A via hmmscan --cut_ga — tRNA-synt_2b (PF00587.31), tRNA_edit (PF04073.21), HGTP_anticodon (PF03129.26)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG0442
  • Curated reference: UniProt P9WFT9 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 95.2)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 73 functional partner(s); context anchor efpA
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_003024|Rv2845c|proS
MITRMSELFLRTLRDDPADAEVASHKLLIRAGYIRPVAPGLYSWLPLGLRVLRNIERVIRDEMNAIGGQEILFPALLPRAPYETTNRWTQYGDSVFRLKDRRGNDYLLGPTHEELFTLTVKGEYSSYKDFPLTLYQIQTKYRDEARPRAGILRAREFVMKDSYSFDIDAAGLKAAYHAHREAYQRIFDRLQVRYVIVSAVSGAMGGSASEEFLAESPSGEDAFVRCLESGYAANVEAVVTARPDTLPIDGLPEAVVHDTGDTPTIASLVAWANEADLGRTVTAADTLKNVLIKVRQPGGDTELLAIGVPGDREVDDKRLGAALEPADYALLDDDDFAKHPFLVKGYIGPKALRENNVRYLVDPRIVDGTSWITGADQPGRHVVGLVAGRDFTADGTIEAAEVREGDPSPDGAGPLVMARGIEIGHIFQLGSKYTDAFTADVLGEDGKPVRLTMGSYGIGVSRLVAVVAEQHHDELGLRWPSTVAPFDVHLVIANKDAQARAGATALAADLDRLGVEVLLDDRQASPGVKFKDAELLGMPWIVVVGRGWADGVVELRDRFSGQTRELVAGASLATDIAAAVTG